| ROMIDEPSIN |
208574 |
001 |
NDA |
ROMIDEPSIN |
SOLUTION;INTRAVENOUS |
10MG/2ML (5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** |
Yes
|
No
|
2020/03/13
|
2020/03/13
|
TEVA PHARMS USA INC |
Discontinued |
| ROMIDEPSIN |
208574 |
001 |
NDA |
ROMIDEPSIN |
SOLUTION;INTRAVENOUS |
10MG/2ML (5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** |
Yes
|
No
|
2020/03/13
|
2020/03/13
|
TEVA PHARMS USA INC |
Discontinued |
| ROMIDEPSIN |
208574 |
002 |
NDA |
ROMIDEPSIN |
SOLUTION;INTRAVENOUS |
27.5MG/5.5ML (5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** |
Yes
|
No
|
2020/03/13
|
2020/03/13
|
TEVA PHARMS USA INC |
Discontinued |
| ROMIDEPSIN |
208574 |
002 |
NDA |
ROMIDEPSIN |
SOLUTION;INTRAVENOUS |
27.5MG/5.5ML (5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** |
Yes
|
No
|
2020/03/13
|
2020/03/13
|
TEVA PHARMS USA INC |
Discontinued |
| ROMIDEPSIN |
206254 |
001 |
ANDA |
ROMIDEPSIN |
POWDER;INTRAVENOUS |
10MG/VIAL |
No
|
No
|
2021/10/12
|
2021/10/12
|
FRESENIUS KABI USA |
Prescription |